Increased p21 expression and complex formation with cyclin E/CDK2 in retinoid-induced pre-B lymphoma cell apoptosis

被引:21
作者
Bao, George C.
Wang, Jian-Guang
Jong, Ambrose
机构
[1] Univ So Calif, Childrens Hosp Los Angeles, Keck Sch Med, Div Hematol Oncol,Saban Res Inst, Los Angeles, CA 90027 USA
[2] Childrens Hosp Los Angeles, Saban Res Inst, Div Hematol Oncol, Los Angeles, CA 90027 USA
[3] Sun Yat Sen Univ, Affiliated Hosp 2, Dept Oral & Maxillofacial Surg, Guangzhou, Peoples R China
[4] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA
来源
FEBS LETTERS | 2006年 / 580卷 / 15期
关键词
retinoid; apoptosis; p21; induction; CDK2; activity; p21-CDK2; interaction;
D O I
10.1016/j.febslet.2006.05.052
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cip/Kip family protein p21, a cyclin-dependent kinase (CDK) inhibitor, is directly transactivated by retinoic acid receptor alpha (RAR alpha) upon retinoic acid (RA):RAR alpha binding. Yet the role of p21 upregulation by RA in lymphoma cells remains unknown. Here, we show that, in human pre-B lymphoma Nalm6 cells, RA-induced proliferation inhibition results from massive cell death characterized by apoptosis. Upregulated p21 by RA accompanies caspase-3 activation and precedes the occurrence of apoptosis. p21 induction leads to increased p21 complex formation with cyclin E/CDK2, which occurs when cyclin E and CDK2 levels remain constant. CDK2 can alternatively promote apoptosis, but the mechanisms remain unknown. Data presented here suggest a novel RA-signaling, by which RA-induced p21 induction and complex formation with cyclin E/CDK2 diverts CDK2 function from normally driving proliferation to alternatively promoting apoptosis. (c) 2006 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:3687 / 3693
页数:7
相关论文
共 57 条
[41]   IDENTIFICATION OF THE ACTIVE-REGION OF THE DNA-SYNTHESIS INHIBITORY GENE P21(SDI1/CIP1/WAF1) [J].
NAKANISHI, M ;
ROBETORYE, RS ;
ADAMI, GR ;
PEREIRASMITH, OM ;
SMITH, JR .
EMBO JOURNAL, 1995, 14 (03) :555-563
[42]   CLONING OF P27(KIP1), A CYCLIN-DEPENDENT KINASE INHIBITOR AND A POTENTIAL MEDIATOR OF EXTRACELLULAR ANTIMITOGENIC SIGNALS [J].
POLYAK, K ;
LEE, MH ;
ERDJUMENTBROMAGE, H ;
KOFF, A ;
ROBERTS, JM ;
TEMPST, P ;
MASSAGUE, J .
CELL, 1994, 78 (01) :59-66
[43]   Stimulation of RAR alpha activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7 [J].
RochetteEgly, C ;
Adam, S ;
Rossignol, M ;
Egly, JM ;
Chambon, P .
CELL, 1997, 90 (01) :97-107
[44]   Oncogenic functions of tumour suppressor p21 Waf1/Cip1/Sdi1:: association with cell senescence and tumour-promoting activities of stromal fibroblasts [J].
Roninson, IB .
CANCER LETTERS, 2002, 179 (01) :1-14
[45]   Alterations in expression, binding to ligand and DNA, and transcriptional activity of rearranged and wild-type retinoid receptors in retinoid-resistant acute promyelocytic leukemia cell lines [J].
Rosenauer, A ;
Raelson, JV ;
Nervi, C ;
Eydoux, P ;
DeBlasio, A ;
Miller, WH .
BLOOD, 1996, 88 (07) :2671-2682
[46]   CDK inhibitors:: positive and negative regulators of G1-phase progression [J].
Sherr, CJ ;
Roberts, JM .
GENES & DEVELOPMENT, 1999, 13 (12) :1501-1512
[47]  
Sundaresan A, 1997, CELL GROWTH DIFFER, V8, P1071
[48]   Resistance to Fas-mediated apoptosis:: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP [J].
Suzuki, A ;
Tsutomi, Y ;
Akahane, K ;
Araki, T ;
Miura, M .
ONCOGENE, 1998, 17 (08) :931-939
[49]   Involvement of all-trans-retinoic acid in the breakdown of retinoic acid receptors α and γ through proteasomes in MCF-7 human breast cancer cells [J].
Tanaka, T ;
de la Concepción, MLR ;
De Luca, LM .
BIOCHEMICAL PHARMACOLOGY, 2001, 61 (11) :1347-1355
[50]   P27, A NOVEL INHIBITOR OF G1 CYCLIN-CDK PROTEIN-KINASE ACTIVITY, IS RELATED TO P21 [J].
TOYOSHIMA, H ;
HUNTER, T .
CELL, 1994, 78 (01) :67-74